David G. Kelly - 15 Jun 2022 Form 4 Insider Report for Iterum Therapeutics plc (ITRM)

SEC form
4
Accepted by SEC
17 Jun 2022, 17:01:35 UTC
Prior SEC filing
25 Jun 2021
Source filing
View source filing
Filing notes and source

Key filing fact

David G. Kelly filed Form 4 for Iterum Therapeutics plc (ITRM) on 17 Jun 2022.

Key facts

  • This page summarizes David G. Kelly's Form 4 filing for Iterum Therapeutics plc (ITRM).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 17 Jun 2022, 17:01.

Change

  • Previous filing in this sequence was filed on 25 Jun 2021.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ITRM transaction Derivative

Share Option (Right to Buy)

Award

Transaction value
$0
Shares
+647,059
Change %
Price
$0.000000
Shares after
647,059
Date
15 Jun 2022
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
647,059
Exercise price
$0.2100
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Subject to the reporting person providing continuous service to the Issuer and the other terms and conditions of the Issuer's 2018 Amended and Restated 2018 Equity Incentive Plan, as amended, the shares subject to this option shall vest in full on June 15, 2023

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .